Cargando…
A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine
Kv1.2 channels, encoded by the KCNA2 gene, are localized in the central and peripheral nervous system, where they regulate neuronal excitability. Recently, heterozygous mutations in KCNA2 have been associated with a spectrum of symptoms extending from epileptic encephalopathy, intellectual disabilit...
Autores principales: | Imbrici, Paola, Conte, Elena, Blunck, Rikard, Stregapede, Fabrizia, Liantonio, Antonella, Tosi, Michele, D’Adamo, Maria Cristina, De Luca, Annamaria, Brankovic, Vesna, Zanni, Ginevra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469797/ https://www.ncbi.nlm.nih.gov/pubmed/34576077 http://dx.doi.org/10.3390/ijms22189913 |
Ejemplares similares
-
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia
por: Dinoi, Giorgia, et al.
Publicado: (2022) -
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel
por: Imbrici, Paola, et al.
Publicado: (2021) -
KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine
por: Müller, Peter, et al.
Publicado: (2023) -
Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias
por: Garone, Giacomo, et al.
Publicado: (2020) -
Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches
por: D’Adamo, Maria Cristina, et al.
Publicado: (2020)